BOARD MEMBERS
Ali Guermazi, MD, PhD
President (2019 - 2029)
​
Dr Guermazi is a Professor of Radiology & Medicine at Boston University School of Medicine. He is one of the three founders of the International Workshop on Osteoarthritis Imaging. Dr. Guermazi’s research focuses on imaging the musculoskeletal system, especially in characterizing the magnetic resonance imaging (MRI) and X-ray changes that occur in osteoarthritis (OA). He has been repeatedly involved in studies on meniscus, cartilage, synovitis and bone marrow lesions in knees, hip and spine and is extremely familiar with how best to acquire the images which optimize their assessment and with measuring these lesions. Recognized for scientific contributions in the MRI-based diagnosis and disease progression assessment of OA, he has been an MRI reader for assessing meniscus, cartilage, synovitis and bone marrow lesions in large NIH-funded studies (e.g., the Osteoarthritis Initiative (OAI), the Multicenter Osteoarthritis Study (MOST), the Health Aging and Body Composition (Health ABC) study, the Boston Osteoarthritis Knee study (BOKS), and the Framingham study). Dr. Guermazi is a principal investigator (PI) for several NIH-funded OAI ancillary projects. His work also focuses on imaging in sports medicine and especially the role of MRI in preventing sports injuries and predicting return to play.
He is the founder and Director of the Quantitative Imaging Center (QIC) within the Department of Radiology at Boston University School of Medicine, Boston, MA, a research group focusing on Musculoskeletal Radiology and especially MRI that provides radiological analysis services for industry, foundation or NIH-sponsored trials.
Professor Guermazi was the Deputy Editor of the musculoskeletal imaging section for the RADIOLOGY journal from 2013-2019. He has authored or co-authored more than 560 peer-reviewed papers and made numerous scientific presentations at national and international osteoarthritis, rheumatology and radiology meetings.
Tuhina Neogi, MD, PhD
Secretary (2019 - 2029)
​​
Dr. Neogi is a Professor and Chief of Rheumatology at Boston University School of Medicine and Professor of Epidemiology and Boston University School of Public Health. Her research focused primarily on risk factors for knee osteoarthritis and gout, pain mechanisms in knee osteoarthritis, as well as methodologic issues of relevance for rheumatic diseases. She has continuous peer-reviewed foundation and NIH funding since 2003 and has over 200 peer-reviewed publications to date. Dr. Neogi is a past chair of the FDA Arthritis Advisory Committee, serves/served on the boards two international societies: Osteoarthritis Research Society International (OARSI) and Gout, Hyperuricemia, and Crystal-Associated Diseases Network (G-CAN), and on committees for the American College of Rheumatology (ACR) and International Association for the Study Pain (IASP), among others. Her work has been recognized with the prestigious 2014 ACR Henry Kunkel Young Investigator Award for outstanding and promising independent contributions to rheumatology research (awarded to no more than one clinical researcher and/or one basic science researcher each year). She has also engaged in developing new classification criteria for a number of rheumatic diseases.
In addition to research, clinical work, and teaching, one of her key roles is to mentor trainees and junior faculty in musculoskeletal disease-related research. To that end, she was awarded the 2016 Robert Dawson Evans Research Mentoring Award. Dr. Neogi is also leading the new CTSI Research Career Support Program initiative, PRIME (Pathways to Research Independence and Mentoring Excellence), which aims to support early career mentored researchers to successfully transition to becoming independent researchers. She is on the Core Steering committee for the 2019 ACR-AF Osteoarthritis Treatment Guidelines and is co-PI of the 2020 ACR Gout Treatment Guidelines.
Edwin Oei
Vice President (2026-2029)
Dr Edwin Oei is a Professor of Musculoskeletal Imaging and Section Chief of Musculoskeletal Radiology at the Department of Radiology & Nuclear Medicine of Erasmus MC, University Medical Center, Rotterdam, The Netherlands. He completed his medical studies, radiology residency, as well as a PhD degree on MRI for traumatic knee injury, all at Erasmus MC Roterdam. He also holds an MSc degree in Clinical Epidemiology.
Dr. Oei is the principal investigator of the Advanced Musculoskeletal Imaging Research Erasmus MC (ADMIRE) lab. His research is focused primarily on imaging in osteoarthritis and spans a broad range of topics, including technical development and optimization, validation studies with quantitative MRI, CT, and ultrasound, as well as clinical research employing semiquantitative and quantitative imaging methods. He is also deeply involved in population-based imaging within the Rotterdam Study and Generation R, exploring the epidemiology and progression of osteoarthritis. More recently, his work has expanded to hybrid imaging with PET/MRI, photon-counting CT, and the use of artificial intelligence. In addition to osteoarthritis, his research also encompasses other common musculoskeletal disorders such as osteoporosis and sports injuries. He has obtained research funding from various sources including the Dutch Arthritis Foundation, Dutch Research Council, Radiological Society of North America, National Basketball Association, and he is an author and co-author of over 260 scientific peer reviewed publications.
Dr. Oei is an active member of various international professional societies and committees. He is a past president of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) and the Musculoskeletal MRI Study Group of ISMRM and a member of the European Imaging Biomarkers Alliance (EIBALL) Subcommittee of the European Society of Radiology. Within the European Society of Musculoskeletal Radiology (ESSR), he currently serves as vice-chair of the Research Committee and as a long-standing member of the Arthritis Subcommittee. He co-organized the hybrid 15th IWOAI meeting in Rotterdam in 2021.
Wolfgang Wirth
​Treasurer (2026-2029)
Wolfgang Wirth is a computer scientist with 25 years of experience in medical image analysis and quantitative musculoskeletal imaging. His work is centered on image analysis methodology development, large-scale data analysis, and the application of quantitative imaging biomarkers to understand and monitor osteoarthritis progression and therapeutic responses, particularly in the context of large cohort studies and interventional clinical trials.
He is the CEO of Chondrometrics GmbH (Germany), a company providing quantitative image analysis services and biomarker expertise to customers from both industry and academia. In parallel, he serves as a researcher at Paracelsus Medical University Salzburg (Austria), contributing to advanced osteoarthritis imaging research and joint tissue assessment.
Dr. Wirth has contributed to several large-scale projects and interventional trials, supporting the development, validation, and application of imaging biomarkers in multicenter studies. He has authored or co-authored almost 200 peer-reviewed publications, reflecting his long-standing commitment to advancing quantitative imaging science and its translation into clinical research.
Dr. Wirth is co-organizer of the 2026 International Workshop on OA Imaging, together with Prof. Frank Roemer, Erlangen.
John Carrino, MD, PhD
Member (2019 - 2029)
​
Dr. Carrino is a Professor of Radiology at Weill Medical College of Cornell University, New York, and Vice Chair of Radiology and Imaging at Hospital for Special Surgery, New York. He is a Musculoskeletal Radiologist with particular expertise in diagnostic imaging, percutaneous image-guided intervention utilizing multiple modalities, and medical informatics. He has research experience as a primary investigator or co-investigator with NIH awards and academic industrial collaborations. He is an author and co-author on over 250 peer-reviewed publications. He is an Associate Editor of imaging for Arthritis & Rheumatology.
Dr. Carrino is an active participant in several national and international scientific and professional societies. He acts as an ACR (American College of Radiology) representative to the DICOM (Digital Imaging COmmunication in Medicine) Standards Committee. He has participated in research study sections for the NIH, RSNA, and VA as well as in panels for the FDA. Dr. Carrino has served on the Advisory Committee of the FDA Radiology Devices Panel, looking at computer aided diagnosis (CAD). He is a formal collaborator in the Laboratory for Imaging in Surgery, Therapy and Radiology at Johns Hopkins University. He contributes to the leadership of several national and international scientific and multidisciplinary professional societies such as North American Spine Society (NASS) and Spine Interventional Society (SIS).
Jeff Duryea, PhD
Member (2019 - 2029)
​​​
Dr. Duryea is an Associate Professor of Radiology at Brigham and Women’s Hospital (BWH), Harvard Medical School and director of the BWH Quantitative Musculoskeletal Imaging Group (QMIG). A physicist by training, Dr. Duryea specializes in the development and application of software-based quantitative image analysis tools to assess OA progression. He is the author and co-author of over 95 peer-reviewed publications and has been the principal investigator of 7 extramural National Institutes of Health (NIH) and foundation grants. An active member of the Osteoarthritis Initiative (OAI) community, his laboratory has provided measurements of radiographic joint space width for over 35,000 knee radiographic images from that study, which are part of the OAI public data release. In 2013-2014 Dr. Duryea served as a member of the OARSI Clinical Trial Guidelines Imaging Group and has also served on the Osteoarthritis Research Society International (OARSI) program and ethics committees.
Tom Turmezei ​
Member (2026-2029)
Dr Turmezei has been a Consultant Musculoskeletal Radiologist at the Norfolk and Norwich University Hospital, UK, since 2017, and has over a decade of diagnostic and interventional experience across the spectrum of musculoskeletal disorders that has included the prestigious musculoskeletal radiology fellowship at the Royal National Orthopaedic Hospital, Stanmore, UK (2016–2017).
In 2022, Dr Turmezei was promoted to Honorary Professor at the University of East Anglia, UK, having previously undertaken the Welcome Trust Clinical PhD Fellowship in the Medical Imaging Group at the Cambridge University Engineering Department, UK (2012–2016). His transdisciplinary research focused on development and technical validation of quantitative 3-D CT and MRI analysis techniques for evaluating bone, joint space and articular cartilage, but he has also developed several semi-quantitative osteoarthritis grading systems from CT imaging, with substantial experience in reproducibility testing.
A two-time recipient of the Young Investigator Award from the International Workshop of Osteoarthritis Imaging (IWOAI 2016 & 2019), Dr Turmezei was a co-organizer of the 2025 meeting in Cambridge, UK, and has served on the Scientific Advisory Board of the Society since 2019. He also served on the editorial board of the society journal, Osteoarthritis Imaging, from 2021 to 2024. These positions, along with several other international advisory and leadership roles, have helped drive a year-on-year increase in the profile of CT in the osteoarthritis imaging community.
Dr Turmezei has participated in several major international research collaborations, including the Multicenter Osteoarthritis Study (USA) and AGES-Reykjavik (Iceland), and has supervised postgraduate researchers across the world. From 2015 to 2025, he was lead radiologist for the pan-European ADIPOA2 trial looking at the efficacy of mesenchymal stromal cells in the treatment of knee osteoarthritis. Combining his clinical and research expertise in osteoarthritis and osteoporosis, Dr Turmezei has provided consultancy to Curvebeam AI, Pfizer, GSK, and Amgen, and oversaw imaging for more than 150 clinical trials during his time as Imaging Research Lead in Norwich, UK (2018–2025). He has also been a member of the Scientific Advisory Board for Chondrometrics GmbH since 2024.
Dr Turmezei is also an award-winning academic writer and editor, serving as Imaging Editor for Gray’s Anatomy (Elsevier) since 2017. In 2020 he was awarded the Roentgen Professorship by the UK Royal College of Radiologists (RCR) for his academic achievements and inspiration of radiologists into research. He has continued to mentor radiologists and imaging scientists in the UK through his leadership with the RCR and the National Institute for Health and Care Research, including as creator and host of the CRASH! Podcast.
Mylene Jansen​
Member (2026-2029)
Dr. Mylene Jansen is an Assistant Professor at department of Rheumatology & Clinical Immunology of the University Medical Center Utrecht, The Netherlands. Her research focuses on imaging biomarkers of structural progression and repair in osteoarthritis. She has played a leading role in clinical and imaging studies on joint-preserving treatments such as knee joint distraction.
Dr. Jansen also contributes to the large European IMI-APPROACH consortium as data manager and investigator, where she applies imaging analyses to improve phenotyping and prediction of OA progression. Her broader work explores the relationships between joint structure, clinical symptoms, and biomechanics across imaging modalities, including MRI, CT, and radiography. Through collaborations within multidisciplinary imaging, rheumatology, and orthopedics networks, she aims to advance the use of imaging to better understand and monitor disease progression and modification in osteoarthritis.
Dr. Jansen is the author of >50 peer-reviewed publications and is currently funded by a personal Veni grant from the Netherlands Organisation for Health Research and Development (ZonMW) and ReumaNederland.
Mohamed Jarraya​
Member (2026-2029)
Dr. Mohamed Jarraya is a board-certified musculoskeletal radiologist with a strong focus on advanced MRI and CT imaging of osteoarthritis. Dr. Jarraya is an Assistant Professor of Radiology at Harvard Medical School and an Attending Radiologist in the Musculoskeletal Division at Massachusetts General Hospital, Boston, USA. He also serves as Head of Musculoskeletal Radiology Research at Mass General Brigham.
Dr. Jarraya is an internationally recognized physician-scientist and has authored over 80 peer-reviewed scientific publications, many in leading radiology, rheumatology, and orthopedic journals. His research focuses on MRI- and CT-based imaging biomarkers of osteoarthritis, pain phenotyping, imaging of inflammation, crystal arthropathies, post-traumatic joint degeneration, and applications of advanced imaging technologies including photon-counting CT, PET imaging, and artificial intelligence.
He has made substantial contributions to the development, validation, and application of quantitative and semi-quantitative imaging tools for comprehensive joint assessment in both cross-sectional and longitudinal studies. Dr. Jarraya has been a key investigator and imaging expert for several large, landmark epidemiologic and longitudinal cohorts, including MOST (Multicenter Osteoarthritis Study), OAI (Osteoarthritis Initiative), Framingham Study, and international Olympic and Paralympic Games imaging projects.
A major focus of Dr. Jarraya’s work is understanding the discordance between structural joint damage and pain, with particular emphasis on identifying imaging markers associated with different pain phenotypes and predicting disease incidence and progression. His research also addresses post-traumatic joint changes, early disease detection in athletes and young populations, and translational imaging strategies to optimize clinical trials in osteoarthritis.
Dr. Jarraya is actively involved in scientific leadership and peer review. He previously served as Associate Editor for BMC Musculoskeletal Disorders and Guest Editor for Skeletal Radiology, and Osteoarthritis Imaging. He is a regular invited speaker at major international conferences in radiology, rheumatology, orthopedics, and osteoarthritis research.
Dr. Jarraya is a Board Member of the International Society of Osteoarthritis Imaging (ISOAI) and an active contributor to international initiatives focused on advancing imaging standards, biomarkers, and clinical trial methodology in osteoarthritis. Through extensive global collaborations with leading academic institutions, Dr. Jarraya continues to play a key role in shaping the future of osteoarthritis imaging and translational musculoskeletal research.
Nobutake Ozeki
Member (2026-2029)
Dr. Nobutake Ozeki belongs to the Department of Orthopaedic Surgery and the Center for Stem Cell and Regenerative Medicine at the Institute of Science Tokyo. He has been actively involved in developing 3D MRI reconstruction software and has published numerous studies on three-dimensional MRI analysis of the knee. His clinical and research interests include regenerative medicine using synovial mesenchymal stem cells for cartilage and meniscal repair, as well as basic experimental research in musculoskeletal tissue regeneration.
As an orthopaedic surgeon and sports medicine specialist, he is an expert in joint-preserving procedures such as anterior cruciate ligament reconstruction, meniscus repair, and high tibial osteotomy. He has authored several peer-reviewed publications related to meniscal surgery and knee biomechanics.
In the sports field, he serves as a team physician for the Yomiuri Giants, a professional baseball team based in Tokyo, Japan. He has also contributed to on-site medical services at major international events, including the 2019 Rugby World Cup in Japan and the Tokyo 2020 Olympic and Paralympic Games (Athletes’ Village/venue clinics). He is scheduled to serve as an Event Medical Officer for the 2026 Lacrosse World Cup Japan.
Frank Roemer, MD
Ex Officio Member, Editor-in-Chief, Osteoarthritis Imaging (2019-2029)
​​
Dr. Roemer is a German board-certified musculoskeletal radiologist with a strong focus on MRI. He is Professor of Radiology at the Friedrich-Alexander University of Erlangen-Nürnberg, Adjunct Professor of Radiology at Boston University School of Medicine (BUSM), Co-Director of the Quantitative Imaging Center at BUSM and attending radiologist and Director of Musculoskeletal Research at the Department of Radiology at the Universitätsklinikum Erlangen, Erlangen, Germany.
Dr. Roemer is an internationally recognized scientist and has authored > 340 scientific peer reviewed publications in the field of musculoskeletal radiology. Dr. Roemer’s research interests include imaging of musculoskeletal diseases, with a focus on MRI and osteoarthritis, and imaging in sports medicine. He is regularly invited internationally to present at major scientific conferences, has authored multiple book chapters, and educational and scientific exhibits at various international radiological, orthopedic and rheumatological meetings.
He developed and validated several instruments for tissue characterization in osteoarthritis and comprehensive joint assessment using quantitative and semiquantitative evaluation tools for application in cross-sectional and longitudinal fashion. He has been one of the main MRI readers for large epidemiologic studies including OAI; MOST, Framingham, KANON, VIDEO and others. Focus of his research is the application of those MRI-based instruments to better understand the natural history of degenerative joint diseases and particularly focus on prediction models to isolate patients at higher risk for disease incidence and progression. An additional focus is the role of post-traumatic changes and later OA development, which included development and introduction of the method of CT-arthrography in an animal model, multi-dimensional assessment of ACL injury and its sequelae and evaluation of radiographic imaging markers in young persons at increased risk for disease including young athletes.
He is Associate Editor for Imaging of one the leading journals of orthopedics and rheumatology “Osteoarthritis & Cartilage” since 2011. He has been Associate Editor for “BMC Musculoskeletal Disorders” from 2011-2013 and is currently holding a position as Editorial Advisor for that journal. He is also Editorial Board member of “European Radiology”, the number 2 general interest radiology journal in the field. He is working in close collaboration with multiple leading scientific institutions worldwide focusing on osteoarthritis and MSK disorders.
He is consortium partner in the European Union-funded multi-center APPROACH project, which brings together a strong team from European clinical centers (cohorts), basic research institutes (state-of-the-art tools) and SME/Industry (certified tool analyses and logistics) which also collaborate with large US-based OAI and MOST cohorts.
Jos Runhaar
Co-Opted Member (2026-2029)
​
Dr. Jos Runhaar is an Associate Professor at the Department of General Practice of Erasmus MC University Medical Center Rotterdam, the Netherlands. His research focusses on “Prevention and early treatment of osteoarthritis”. His research group aims to improve the diagnosis of musculoskeletal disorders by general practitioners and physiotherapists and to shift the treatment of musculoskeletal disorders to the early disease phase; even to a phase where primary prevention becomes possible.
Dr. Runhaar is trained as a Human Movement Scientist at the Vrije Universitiet Amsterdam, after which he started his PhD at the Department of General Practice of Erasmus MC. For his PhD, dr. Runhaar authored the first-ever preventive RCT in OA research and acted as PI for the long-term follow-up of this trial during his post-doc. His expertise spans a broad range of OA research, including the development and validation of early-stage OA classification and diagnostic criteria, OA biomarker research, including those derived from imaging, OA prevention, and trial evaluating conservative and primary care intervention for OA. He has published >150 peer-reviewed articles; the majority in the top 25% of impact factors within his field. In 2023, dr. Runhaar was awarded the ‘Rising Star Award for Clinical Research’ by OARSI.
Dr. Runhaar has a large (inter)national network and served many different scientific committees, including the Research & Training Committee (chair), Program Committee, Ethics & Governance Committee, and the Nomination Committee of OARSI, the Scientific Advisory Board for the Dutch Arthritis Society, the Organizing Committee for the OARSI Imaging Workshop (co-Chair), and multiple international Thesis Assessment Committees. He also serves as expert on the evaluation committee of Research Foundation Flanders (FWO) and the College of Experts for Versus Arthritis.